1 the unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2025, as recommended by the Audit Committee, along with the Limited Review Reports, in compliance with Regulation 33 is annexed herewith as Annexure A. 2 the fundraising by way of the issue of fully-paid up equity shares of the Company to its eligible shareholders as on the record date (to be notified later) on a right basis ('Rights issue'), for a maximum amount up to Rs. 7.5 Crore (the 'Issue'), subject to receipt of necessary approvals, as applicable and in accordance with applicable provisions of the Companies Act, 2013, as amended, Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 ('SEBI (ICDR) Regulations'), as amended, and other applicable laws. 3 the appointment of Dr. Aravind Kumar Madala (DIN: 06994824) as an Additional Director with effect from 1st September, 2025 subject to the approval of the Shareholders.